Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    CAN-004
Previous Study | Return to List | Next Study

Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment (CANVAS)

This study has been terminated.
(Trial terminated per Sponsor direction not due to any safety signal but due to longer than expected clinical & regulatory approvals & enrolment of patients.)
Information provided by (Responsible Party):
Prima BioMed Ltd Identifier:
First received: January 17, 2012
Last updated: April 1, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)